Alzheimer’s drug trials have a long and disappointing track record, with many failing to prove effective. But results released last week from an Alzheimer’s study bolstered hopes. Reisa Sperling, professor of neurology at Brigham and Women’s Hospital, is leading the study. Keith Johnson, professor of radiology at Massachusetts General Hospital, is leading the tau imaging for the study.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?